Non small cell lung cancer patients with ECOG PS2: unsolved questions and lessons from clinical trials

Ann Oncol. 2005 May:16 Suppl 4:iv123-131. doi: 10.1093/annonc/mdi921.

Authors

V Gebbia¹, D Galetta, F De Marinis

Affiliation

¹ Department of Experimental Oncology and Clinical Applications, University of Palermo, Medical Oncology Unit, La Maddalena Clinic for Cancer, Palermo, Italy. [email protected]

PMID: 15923412
DOI: 10.1093/annonc/mdi921

No abstract available

Publication types

Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma, Non-Small-Cell Lung / drug therapy*
Carcinoma, Non-Small-Cell Lung / mortality
Carcinoma, Non-Small-Cell Lung / pathology
Controlled Clinical Trials as Topic
Drugs, Investigational / therapeutic use
Humans
Lung Neoplasms / drug therapy*
Lung Neoplasms / mortality
Lung Neoplasms / pathology
Neoplasm Staging

Substances

Drugs, Investigational